SNORD118: A Potential Drug Target and Biomarker (G727676)

Target Name: SNORD118

NCBI ID: G727676

SNORD118

Other Name(s): U8 | LCC | Small nucleolar RNA, C/D box 118 | small nucleolar RNA, C/D box 118

SNORD118: A Potential Drug Target and Biomarker

SNORD118 (U8) is a protein that is expressed in various tissues and organs, including the brain, heart, and lungs. It is a member of the snodal protein family, which is characterized by the presence of a unique transmembrane domain and a cytoplasmic tail. The snodal protein family is thought to play a role in various physiological processes, including cell signaling, neurotransmitter release, and tissue repair.

Recent studies have identified SNORD118 (U8) as a potential drug target and biomarker. One reason for its potential as a drug target is its unique structure, which allows it to interact with small molecules in a variety of ways. Additionally, its expression is highly regulated in many tissues, which may make it an attractive target for drugs that can modulate its levels or activity.

Another reason for its potential as a drug target is its involvement in various signaling pathways. For example, SNORD118 (U8) has been shown to play a role in the regulation of neurotransmitter release from neurons, which is important for various cognitive and behavioral processes. Additionally, it has been shown to be involved in the regulation of cell proliferation and survival, which may be relevant to the development of certain diseases.

In addition to its potential as a drug target, SNORD118 (U8) has also been identified as a potential biomarker. Its expression is highly regulated in many tissues, which may make it an attractive target for techniques such as RNA sequencing or qRT-PCR. By analyzing the expression patterns of SNORD118 (U8), researchers may be able to gain insights into the underlying mechanisms of its regulation and how it contributes to various physiological processes.

Overall, SNORD118 (U8) is a protein that is worth further investigation as a potential drug target and biomarker. Its unique structure and regulation, as well as its involvement in various signaling pathways, make it an attractive target for small molecules and other therapeutic agents. Further studies are needed to fully understand its role in various physiological processes and its potential as a drug and biomarker.

Protein Name: Small Nucleolar RNA, C/D Box 118

The "SNORD118 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD118 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets